Cargando…
Clinical efficacy analysis of butylphthalide combined with urinary kallidinogenase in treating chronic cerebral circulatory insufficiency
OBJECTIVE: To investigate the clinical effect of butylphthalide combined with urinary kallidinogenase in the treatment of chronic cerebral circulatory insufficiency (CCCI). METHODS: A total of 102 CCCI patients admitted to our hospital from October 2020 to December 2021 were retrospectively enrolled...
Autores principales: | Hu, Bo, Hu, Feifan, Qiao, Yulin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097061/ https://www.ncbi.nlm.nih.gov/pubmed/36811524 http://dx.doi.org/10.1002/brb3.2920 |
Ejemplares similares
-
Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke
por: Qian, Yun, et al.
Publicado: (2019) -
Urinary kallidinogenase for the treatment of cerebral arterial stenosis
por: Zhao, Liandong, et al.
Publicado: (2015) -
Analysis of treatment effect of urinary kallidinogenase combined with edaravone on massive cerebral infarction
por: Ke, Jiang, et al.
Publicado: (2016) -
Human Urinary Kallidinogenase Promotes Angiogenesis and Cerebral Perfusion in Experimental Stroke
por: Han, Lijuan, et al.
Publicado: (2015) -
Human urinary kallidinogenase combined with edaravone in treating acute ischemic stroke patients: A meta‐analysis
por: Yang, Di‐Xiao, et al.
Publicado: (2021)